Millennium Management’s iRadimed IRMD Stock Holding History

Millennium Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.9M	Buy	40,509 +37,307	+1,165%	+$3.73M	﹤0.01%	3221
2025 Q4	$311K	Sell	3,202 -94,982	-97%	-$8.15M	﹤0.01%	5243
2025 Q3	$6.99M	Sell	98,184 -13,444	-12%	-$896K	﹤0.01%	2763
2025 Q2	$6.67M	Buy	111,628 +41,481	+59%	+$2.27M	﹤0.01%	2688
2025 Q1	$3.68M	Buy	70,147 +26,096	+59%	+$1.47M	﹤0.01%	3169
2024 Q4	$2.42M	Sell	44,051 -36,176	-45%	-$1.9M	﹤0.01%	3474
2024 Q3	$4.03M	Sell	80,227 -2,827	-3%	-$130K	﹤0.01%	3037
2024 Q2	$3.65M	Sell	83,054 -14,045	-14%	-$597K	﹤0.01%	3018
2024 Q1	$4.27M	Sell	97,099 -5,657	-6%	-$250K	﹤0.01%	3024
2023 Q4	$4.88M	Buy	102,756 +15,577	+18%	+$655K	﹤0.01%	2812
2023 Q3	$3.87M	Buy	87,179 +31,876	+58%	+$1.48M	﹤0.01%	2954
2023 Q2	$2.64M	Buy	55,303 +9,469	+21%	+$427K	﹤0.01%	3237
2023 Q1	$1.8M	Sell	45,834 -13,510	-23%	-$491K	﹤0.01%	3545
2022 Q4	$1.68M	Buy	59,344 +43,507	+275%	+$1.24M	﹤0.01%	3712
2022 Q3	$476K	Sell	15,837 -19,117	-55%	-$666K	﹤0.01%	5014
2022 Q2	$1.19M	Buy	34,954 +3,238	+10%	+$116K	﹤0.01%	4215
2022 Q1	$1.42M	Buy	+31,716	New	+$1.47M	﹤0.01%	4177
2021 Q4	–	Sell	-11,241	Closed	-$378K	–	7094
2021 Q3	$378K	Buy	+11,241	New	+$382K	﹤0.01%	5616
2020 Q2	–	Sell	-58,561	Closed	-$1.25M	–	4375
2020 Q1	$1.25M	Buy	58,561 +10,856	+23%	+$259K	﹤0.01%	2327
2019 Q4	$1.11M	Buy	47,705 +26,250	+122%	+$613K	﹤0.01%	2955
2019 Q3	$450K	Buy	+21,455	New	+$438K	﹤0.01%	3328
2017 Q1	–	Sell	-24,557	Closed	-$273K	–	3661
2016 Q4	$273K	Sell	24,557 -29,518	-55%	-$318K	﹤0.01%	2946
2016 Q3	$919K	Buy	54,075 +28,856	+114%	+$534K	﹤0.01%	2313
2016 Q2	$549K	Buy	25,219 +4,919	+24%	+$88.5K	﹤0.01%	2446
2016 Q1	$389K	Buy	20,300 +4,128	+26%	+$79K	﹤0.01%	2644
2015 Q4	$453K	Buy	+16,172	New	+$457K	﹤0.01%	2696

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management's IRMD Position: Q1 2026 in Review

Millennium Management increased its iRadimed (IRMD) stake by 1,165% in Q1 2026, buying an estimated $3.73M and bringing the position to 40,509 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3221.

Millennium Management first reported a position in IRMD in Q4 2015 and has held it in 26 quarters since. The position peaked at $6.99M in Q3 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Millennium Management held 40,509 shares of iRadimed worth $3.9M as of Q1 2026.
Millennium Management bought 37,307 iRadimed shares in Q1 2026, an estimated $3.73M.
iRadimed made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3221 holding.
Millennium Management first reported a position in iRadimed in Q4 2015 and has held it in 26 quarters since.
Millennium Management's iRadimed position peaked at $6.99M in Q3 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.